Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;38(1):8-17.
doi: 10.1111/pde.14418. Epub 2020 Nov 10.

Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy

Dana Sous  1 , Amy E Armstrong  2   3 , Jennifer T Huang  4 , Sonal Shah  5 , Valerie M Carlberg  6 , Carrie C Coughlin  3   7
Affiliations
Review

Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy

Dana Sous et al. Pediatr Dermatol. 2021 Jan.

Abstract

Chemotherapies often cause side effects of the skin, nails, and mucosal surfaces. These mucocutaneous toxicities contribute to morbidity and affect quality of life. Identification and management of these drug-induced eruptions is vital to allow for continuation of essential therapies. This review demonstrates the wide range of chemotherapy-induced cutaneous toxicities in children and includes clues for diagnosis as well as tips for counseling and management.

Keywords: cancer; chemotherapy; cutaneous reaction; pediatric; skin.

PubMed Disclaimer

References

REFERENCES

    1. Cox GJ, Robertson DB. Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy. Arch Dermatol. 1986;122(12):1413-1414.
    1. Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol. 2008;59(3):524-529.
    1. Schmiegelow K, Al-Modhwahi I, Andersen MK, et al. Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood. 2009;113(24):6077-6084.
    1. Prabhu AV, Bibee K, English JC. Eruptive melanocytic acral nevi in the setting of 6-mercaptopurine therapy. J Drugs Dermatol. 2017;16(5):516-518.
    1. Perry BM, Nguyen A, Desmond BL, Blattner CM, Thomas RS, Young RJ. Eruptive nevi associated with medications (ENAMs). J Am Acad Dermatol. 2016;75(5):1045-1052.

Substances

LinkOut - more resources